Nationality
American

Year of Birth
1966

• Massachusetts Institute of Technology, M.Sc. in Management; M.Sc.in Chemical Engineering

• University of Texas, Austin, B. S. in Chemical Engineering

1989
Process Engineer, R&D, Ethyl Corporation, The Hague, Netherlands

1990
Engineer/Shift Supervisor, Ethyl Corporation, Brussels, Belgium

1995
Business Development/Marketing Manager, Raychem Corporation, SF Bay Area, USA

1997
Business Planning Manager, Biogen, Cambridge, Massachusetts, USA

1999
Managing Director, United Kingdom and Ireland, Biogen, London, UK

2001
Vice President of Finance, Business Planning, Biogen Idec., Cambridge, Massachusetts, USA

2004
Vice President and General Manager, Neurology Business Unit, Biogen Idec., USA

2006
Senior Vice President, Immunology and Ophthalmology Business Unit, Genentech, USA

2010
Senior Vice President, BioOncology Business Unit, Genentech, USA

2013
Global Product Strategy Head/Chief Marketing Officer, Roche Pharmaceuticals, Basel, Switzerland

2016
Head of North American Operations, Genentech, USA

2017-2018
Chief Executive Officer, Genentech, USA

2019-present
CEO Roche Pharmaceutical

2019-present
Chugai Pharmaceuticals

• FHI (Flatiron Health, Inc.)

• FMI (Foundation Medicine, Inc.)

• GNE (Genentech, Inc.)

• Spark Therapeutics

• 2017-2018
  BIO (Biotechnology Innovation Organization)

• 2019-2020
  PhRMA (Pharmaceutical Research and Manufacturers of America)

• Jan 2021-present
  European Federation of Pharmaceuticals Industries and Associations